Abvc Biopharma, Inc. (ABVC) — DEFA14A Filings
All DEFA14A filings from Abvc Biopharma, Inc.. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (1)
-
ABVC Biopharma Files Definitive Additional Materials
— Mar 25, 2024 Risk: low
ABVC Biopharma, Inc. filed definitive additional materials on March 25, 2024, related to its proxy statement. The filing concerns the company's Schedule 14A, wh
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX